000 01204 a2200361 4500
005 20250514234437.0
264 0 _c20051103
008 200511s 0 0 cze d
022 _a0008-7335
024 7 _a10.1016/s1567-5688(05)80613-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKalousová, M
245 0 0 _a[Advanced glycation and oxidation products in patients with atherosclerosis].
_h[electronic resource]
260 _bCasopis lekaru ceskych
_c2005
300 _a385-9; discussion 389-90 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aArteriosclerosis
_xblood
650 0 4 _aBlood Proteins
_xmetabolism
650 0 4 _aFemale
650 0 4 _aGlycation End Products, Advanced
_xblood
650 0 4 _aHumans
650 0 4 _aLysine
_xanalogs & derivatives
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOxidation-Reduction
700 1 _aZák, A
700 1 _aSoukupová, J
700 1 _aStípek, S
700 1 _aMalbohan, I M
700 1 _aZima, T
773 0 _tCasopis lekaru ceskych
_gvol. 144
_gno. 6
_gp. 385-9; discussion 389-90
856 4 0 _uhttps://doi.org/10.1016/s1567-5688(05)80613-0
_zAvailable from publisher's website
999 _c15701356
_d15701356